High Point Advisor Group LLC Aptinyx Inc. Transaction History

High Point Advisor Group LLC

  • $1.4 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$2.21 - $2.89 $26,058 - $34,075
-11,791 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$2.93 - $4.3 $34,547 - $50,701
11,791 New
11,791 $48,000
Q3 2020

Nov 06, 2020
SELL
$3.05 - $4.99 $70,150 - $114,770
-23,000 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$1.99 - $4.4 $45,770 - $101,200
23,000 New
23,000 $114,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email